Springer Nature 2018-2022

Publishing open access in 2,000 hybrid journals at no cost to the author.

Publisher
Springer
Deal duration
2018-2022
2018
2086
2019
2106
2020
2267
2021
2138
2022
1775
Status licence
Current

 

License and conditions

  • Articles by corresponding authors from Dutch universities (including University Medical Centers) and the KNAW will be published in open access, at no cost to the author.
  • The agreement applies to more than 2,000 hybrid journals within the Springer OpenChoice programme, with the exception of titles from learned societies, BioMedCentral and SpringerOpen.
  • Use the Open Access Journal Browser to find out if a specific journal is part of the agreement
  • Publication types that are part of the agreement: original research articles, review articles, brief communication,  continuing education.
  • Note that this agreement covers a maximum of 2,080 publication per year.
  • On the 21th of November the consortium article quota for 2022 with Springer is reached. From that moment on corresponding authors have to pay an Article Processing Charge (APC) to make their article open access. Pay attention: from then on in the Springer publication workflow the message “Open access at no costs for you” will be replaced by “Should you choose to publish open access below, an article-processing charge (APC) will apply”; when choosing for open access you will now be presented with an invoice unless you choose for ‘publish subscription’. In the last case you do not publish open access. Authors are advised to contact the OA representative of their university for more help or more information.

How does it work?

  • At article acceptance you will be asked to confirm your affiliation by choosing it in the “Special Affiliation” drop-down menu and agree to the open access copyright and license terms.
  • The selected institute will verify your affiliation.
Meer informatie

More information on Springers website.

This contract discloses the 'License Details including Attachment 1, Customer and Licensee Information and The Product Terms including Schedules'.

You are here

Dutch National website providing information for academics about the advantages of open access to publicly financed research

About this website
 

Contact

Follow us